Eli Lilly: GLP-1's Potential In More Indications Should Unlock Significant Value Seeking Alpha, 31 Jan 2024 Follow Summary I forecast GLP-1 drugs to become the largest-selling pharmaceutical class, with US sales of $150 billion in 2030.